These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30385267)

  • 1. Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis.
    Antinarelli LMR; de Oliveira Souza I; Zabala Capriles PV; Gameiro J; Britta EA; Nakamura CV; Lima WP; da Silva AD; Coimbra ES
    Exp Parasitol; 2018 Dec; 195():78-86. PubMed ID: 30385267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Aminoquinoline Derivatives as Potential Antileishmanial Agents.
    Antinarelli LM; Dias RM; Souza IO; Lima WP; Gameiro J; da Silva AD; Coimbra ES
    Chem Biol Drug Des; 2015 Oct; 86(4):704-14. PubMed ID: 25682728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of novel 4-aminoquinoline/1,2,3-triazole hybrids against Leishmania amazonensis.
    Glanzmann N; Antinarelli LMR; da Costa Nunes IK; Pereira HMG; Coelho EAF; Coimbra ES; da Silva AD
    Biomed Pharmacother; 2021 Sep; 141():111857. PubMed ID: 34323702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
    Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
    Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
    Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
    Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VOSalophen: a vanadium complex with a stilbene derivative-induction of apoptosis, autophagy, and efficiency in experimental cutaneous leishmaniasis.
    Machado PA; Moraes JOF; Carvalho GSG; Lima WP; Macedo GC; Britta EA; Nakamura CV; da Silva AD; Cuin A; Coimbra ES
    J Biol Inorg Chem; 2017 Aug; 22(6):929-939. PubMed ID: 28597089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
    Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
    Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
    Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD
    Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis.
    da Cunha-Júnior EF; Pacienza-Lima W; Ribeiro GA; Netto CD; do Canto-Cavalheiro MM; da Silva AJ; Costa PR; Rossi-Bergmann B; Torres-Santos EC
    J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the 7-chloro-4-(3-hydroxy-benzilidenehydrazo)quinoline derivative against infection caused by Leishmania amazonensis.
    Antinarelli LMR; Souza MVN; Coelho EAF; Lima WP; Coimbra ES
    Rev Soc Bras Med Trop; 2020; 53():e20200091. PubMed ID: 32578713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
    da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
    Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-butyl-[1-(4-methoxy)phenyl-9H-β-carboline]-3-carboxamide prevents cytokinesis in Leishmania amazonensis.
    Stefanello TF; Panice MR; Ueda-Nakamura T; Sarragiotto MH; Auzély-Velty R; Nakamura CV
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7112-20. PubMed ID: 25224005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5 induces different cell death pathways in promastigotes of Leishmania amazonensis.
    Mendes EA; Desoti VC; Silva Sde O; Ueda-Nakamura T; Dias Filho BP; Yamada-Ogatta SF; Sarragiotto MH; Nakamura CV
    Chem Biol Interact; 2016 Aug; 256():16-24. PubMed ID: 27317947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.